Gilde Healthcare Mergers and Acquisitions Summary

Private Equity Profile

In the last 3 years, Gilde Healthcare has acquired 1 company.

Gilde Healthcare’s most common sectors for investment are life science (49%) and medical products (22%). The Firm’s most common investment types include venture (76%) and growth capital (14%). In total, Gilde Healthcare has invested in 4 US states and 9 different countries.

In the last 3 years, Gilde Healthcare has exited 8 companies. The Firm’s most common exit type is trade sale (52%). Gilde Healthcare’s largest (disclosed) exit occurred in 2014 when it sold Santaris Pharma A/S for $250M.

Join Mergr to view Gilde Healthcare’s full profile and discover more middle-market private equity firms just like it.

M&A Summary

  • M&A Total Activity62
    • M&A Buy Activity37
    • M&A Sell Activity25
  • Total Sectors Invested 9
  • Total Countries Invested 9
  • M&A Buy/Sell Connections 26
  • M&A Advisors 1

Gilde Healthcare

Newtonlaan 91 PO Box 85067 ,
Utrecht, 3508 AB
Netherlands
31 30 219 25 65
www.gildehealthcare.com
healthcare@gildehealthcare.com

Gilde Healthcare is a specialist private equity and venture investor focused on the healthcare sector. The Firm's buyout group targets majority investments throughout Europe (preference for Germany, the Netherlands, Belgium, Austria or Switzerland) and has a focus on healthcare providers, suppliers and service providers active in the healthcare market. The Firm's venture group looks to invest up to €30 million in early stage medtech, diagnostics, digital health and therapeutics companies throughout North America and Europe. Gilde Healthcare was established in 2001 and is headquartered in Utrecht, the Netherlands.


Investment Criteria

Sectors of Interest: Consumer Services, Healthcare Services, Information Technology, Life Science, Medical Products, Test/Measurement Equipment

Target Transaction Types: Buyout (LBO, MBO, MBI), Growth Capital, Secondary Buyout, Venture

Geographic Preferences: East US, Midwest US, South US, West US, Canada, United Kingdom, Western Europe, Eastern Europe, Scandinavia

Transaction Criteria Min Max
Target Revenue - -
Target EBITDA 1 10
Investment Size - 30
Enterprise Value - 75
values in millions of EUR

M&A Summary

Buy vs Sell

Year ≤ '15 '16 '17 '18 '19 '20 T
Buy (0.8/yr) # 33 3 - - 1 - 37
Sell (1.6/yr) # 17 - 2 3 2 1 25
vol $1.5B $191M $1.6B
  62

Most Recent M&A

Company Date Value Type
Symphogen AS 2020-06-04 - Add-on Acquisition
Ballerup, Denmark · www.symphogen.com
BlijWerkt 2019-12-18 - Secondary Buyout
Woerden, Netherlands · www.blijwerkt.nl
Stepping Stones Home & Care B.V. 2019-04-15 - Add-on Acquisition
Oosterbeek, Netherlands · www.steppingstonesbv.nl
Eetgemak BV 2019-03-11 - Secondary Buyout
Katwijk, Netherlands · www.eetgemak.nl
Fysius BV 2018-06-14 - Secondary Buyout
Nijverdal, Netherlands · www.fysius.nl
NightBalance B.V. 2018-05-08 - Add-on Acquisition
The Hague, Netherlands · www.nightbalance.com
STAT-Dx Life S.L. 2018-05-02 191M USD Trade Sale - Public Company
Barcelona, Spain · www.stat-dx.com
ViroClinics Biosciences B.V. 2017-08-29 - Secondary Buyout
Rotterdam, Netherlands · www.viroclinics.eu
BionX Medical Technologies, Inc. 2017-03-15 - Add-on Acquisition
Cambridge, Massachusetts · www.bionxmed.com
NightBalance B.V. 2016-07-05 - Venture
The Hague, Netherlands · www.nightbalance.com
View All >>

M&A by Sector

Sector Current # Value All-time # Value
Life Science 6 (46%) - 18 (49%) -
Medical Products 2 (15%) - 8 (22%) -
Healthcare Services 1 (8%) - 3 (8%) -
Information Technology 2 (15%) - 3 (8%) -
Business Services 1 (8%) - 1 (3%) -
Consumer Services - - 1 (3%) -
Food 1 (8%) - 1 (3%) -
Staffing - - 1 (3%) -
Test/Measurement Equipment - - 1 (3%) -
Total 13 - 37 -

Acquisitions By Geo

State/Country Current # Value All-time # Value
Netherlands 5 (38%) - 13 (35%) -
United States 2 (15%) - 7 (19%) -
  California 1 (8%) - 3 (8%) -
  Massachusetts - - 2 (5%) -
  New Hampshire 1 (8%) - 1 (3%) -
United Kingdom 4 (31%) - 5 (14%) -
Germany - - 3 (8%) -
Denmark - - 3 (8%) -
Spain 1 (8%) - 2 (5%) -
Belgium - - 2 (5%) -
France 1 (8%) - 1 (3%) -
Switzerland - - 1 (3%) -
Total 13 - 37 -

Acquisitions by Deal Type

Type Current # Value All-time # Value
Venture 9 (69%) - 28 (76%) -
Growth Capital 2 (15%) - 5 (14%) -
Buyout (LBO, MBO, MBI) - - 2 (5%) -
Secondary Buyout 2 (15%) - 2 (5%) -
Total 13 - 37 -

Exits by Deal Type

Type Total # Value
Trade Sale - Public Company 10 (40%) 1.5B (91%)
IPO 8 (32%) -
Trade Sale 4 (16%) 150M (9%)
Secondary Sale 3 (12%) -
Total 25 $1.6B

Top M&A Advisors

Financial Deals
William Blair & Co. LLC
1

Deal Values

sell # Total
$100M to $1B 8 $1.6B
< $100M 1 $80M
TOTAL $1.6B
Largest Santaris Pharma A/S
$250M (2014-08-06)

M&A Connections

Deals %
Acquired from
PE Firm(s)
100%
2 100%
Exited to
PE Firm(s)
19%
3 19%
Strategic(s)
81%
13 81%

 Subscribe to unlock this and 155,724
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.0K Private Equity Firms
  • 144K M&A Transactions
  • 152K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.1K M&A Advisors
    (Investment Banks and Law Firms)
  • 45K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.